S. 43
This bill provides a statutory safe harbor from patent infringement claims for generic or biosimilar manufacturers that seek or obtain approval for skinny labels of their drugs.
Learn about this bill’s status and read its full summary in the Pocket Congress app.
Scan to open this page in Pocket Congress